211 related articles for article (PubMed ID: 12920999)
1. [Economic aspects of health care in relation to vaccination programs].
Kuszewski K
Przegl Epidemiol; 2003; 57 Suppl 1():9-13. PubMed ID: 12920999
[No Abstract] [Full Text] [Related]
2. [Issues related to vaccinations in the European Union].
Slusarczyk J
Przegl Epidemiol; 2003; 57 Suppl 1():5-8. PubMed ID: 12920998
[No Abstract] [Full Text] [Related]
3. [Vaccination programs in Poland].
Gładysz A; Rymer W; Inglot M; Rotter K; Knysz B
Przegl Epidemiol; 2004; 58 Suppl 1():80-9. PubMed ID: 15807163
[No Abstract] [Full Text] [Related]
4. [WHO conference: XV meeting of the European Advisory Group for the wide-range vaccination program (EPI) WHO, Warszawa, November 9-10, 1998].
Gałazka A; Magdzik W
Przegl Epidemiol; 1998; 52(4):517-9. PubMed ID: 10321097
[No Abstract] [Full Text] [Related]
5. Harmonization of vaccination policy.
Schaack JC
Biologicals; 1997 Jun; 25(2):243-5. PubMed ID: 9236061
[No Abstract] [Full Text] [Related]
6. [Conference "European Union and Vaccination Issues," September 19, 2002, Warsaw, Poland].
Trybusz A
Przegl Epidemiol; 2003; 57 Suppl 1():3-4. PubMed ID: 12920997
[No Abstract] [Full Text] [Related]
7. Vaccines and vaccination.
Ada G
N Engl J Med; 2001 Oct; 345(14):1042-53. PubMed ID: 11586958
[No Abstract] [Full Text] [Related]
8. Methodological issues and new developments in the economic evaluation of vaccines.
Beutels P; Van Doorslaer E; Van Damme P; Hall J
Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326
[TBL] [Abstract][Full Text] [Related]
9. [Vaccination in a developmental perspective].
Sommerfelt H; Godal T
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2674-7. PubMed ID: 17057768
[No Abstract] [Full Text] [Related]
10. The costs of scaling up vaccination in the world's poorest countries.
Bishai D; McQuestion M; Chaudhry R; Wigton A
Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
[TBL] [Abstract][Full Text] [Related]
11. [Vaccination--value for money?].
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
[TBL] [Abstract][Full Text] [Related]
12. [WHO conference: VIII meeting of National Program Managers of the expanded program on immunization, Warsaw, Poland, November 11-13, 1998].
Gałazka A; Magdzik W
Przegl Epidemiol; 1998; 52(4):521-4. PubMed ID: 10321098
[No Abstract] [Full Text] [Related]
13. The use of cost-effectiveness analysis for pediatric immunization in developing countries.
Gauvreau CL; Ungar WJ; Köhler JC; Zlotkin S
Milbank Q; 2012 Dec; 90(4):762-90. PubMed ID: 23216430
[TBL] [Abstract][Full Text] [Related]
14. How should GAVI build on its success?
Arie S
BMJ; 2011 Sep; 343():d5182. PubMed ID: 21903688
[No Abstract] [Full Text] [Related]
15. [Communicable diseases cost money. Difficult but important to provide the costs for society].
Fredlund H; Giesecke J
Lakartidningen; 1998 Feb; 95(6):522-6. PubMed ID: 9494355
[No Abstract] [Full Text] [Related]
16. Global perspectives on vaccine financing.
Berman S; Giffin RB
Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
[TBL] [Abstract][Full Text] [Related]
17. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
18. [The preventive vaccination program in Poland in comparison with the programs in other European countries].
Magdzik W
Przegl Epidemiol; 1986; 40(2):170-80. PubMed ID: 3809533
[No Abstract] [Full Text] [Related]
19. [National economic consequences of vaccines].
Bergman A; Persson U
Lakartidningen; 2008 May 28-Jun 3; 105(22):1680-4. PubMed ID: 18590011
[No Abstract] [Full Text] [Related]
20. [Epidemiological assessment of an effectiveness of vaccinations].
Zieliński A
Przegl Epidemiol; 2001; 55(1-2):197-205. PubMed ID: 11556081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
